Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Armata Pharmaceuticals (ARMP) Cash & Current Investments: 2013-2018

Historic Cash & Current Investments for Armata Pharmaceuticals (ARMP) over the last 6 years, with Sep 2018 value amounting to $13.4 million.

  • Armata Pharmaceuticals' Cash & Current Investments rose 73.37% to $13.4 million in Q3 2018 from the same period last year, while for Sep 2018 it was $42.2 million, marking a year-over-year increase of 75.49%. This contributed to the annual value of $5.1 million for FY2017, which is negligibly% changed negligibly from last year.
  • According to the latest figures from Q3 2018, Armata Pharmaceuticals' Cash & Current Investments is $13.4 million, which was down 13.17% from $15.4 million recorded in Q2 2018.
  • In the past 5 years, Armata Pharmaceuticals' Cash & Current Investments ranged from a high of $16.6 million in Q1 2015 and a low of $2.2 million during Q1 2017.
  • For the 3-year period, Armata Pharmaceuticals' Cash & Current Investments averaged around $7.6 million, with its median value being $7.1 million (2016).
  • Within the past 5 years, the most significant YoY rise in Armata Pharmaceuticals' Cash & Current Investments was 2,185.81% (2014), while the steepest drop was 67.67% (2014).
  • Over the past 5 years, Armata Pharmaceuticals' Cash & Current Investments (Quarterly) stood at $6.6 million in 2014, then skyrocketed by 42.38% to $9.4 million in 2015, then slumped by 45.23% to $5.1 million in 2016, then remained steady at $5.1 million in 2017, then skyrocketed by 73.37% to $13.4 million in 2018.
  • Its Cash & Current Investments was $13.4 million in Q3 2018, compared to $15.4 million in Q2 2018 and $8.2 million in Q1 2018.